Revvity, Inc. (FRA:PKN)

Market Cap	9.66B -32.5%
Revenue (ttm)	2.43B +3.7%
Net Income	205.02M -10.8%
EPS	1.76 -5.8%
Shares Out	n/a
PE Ratio	47.09
Forward PE	18.78
Dividend	0.24 (0.29%)
Ex-Dividend Date	Jan 16, 2026

Volume	n/a
Average Volume	6
Open	84.34
Previous Close	80.80
Day's Range	83.16 - 84.34
52-Week Range	69.68 - 109.90
Beta	n/a
RSI	43.84
Earnings Date	Feb 2, 2026

About Revvity

Revvity, Inc. provides health sciences solutions, technologies, and services. The company provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and DNA sequencing services; and instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used for testing and screening genetic abnormalities, disorders, and dise...

• Industry: Laboratory Analytical Instruments
• Founded: 1937
• Employees: 11,000
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: PKN

Financial Performance

In 2025, Revvity's revenue was $2.86 billion, an increase of 3.67% compared to the previous year's $2.76 billion. Earnings were $241.20 million, a decrease of -10.79%.

Financial numbers in USD